OTC - PURPOSE SECTION
USES: HELPS PREVENT SUNBURN
Oi Lin Natural Sunscreen SPF 30
- Manufacturer
- Sunrider Manufacturing L.P.
- Effective date
- 2012-02-06
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:46
Label at a glance#
ProductOi Lin Natural Sunscreen SPF 30
Active ingredientTITANIUM DIOXIDE
Label structure7 sections
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
RECOMMENDATION: APPLY OI-LIN® NATURAL EMULSION SPF 30 ON FACE AND OTHER AREAS OF THE BODY TO CREATE A NATURAL BARRIER BETWEEN YOUR SKIN AND HARMFUL EFFECTS OF THE SUN. CHILDREN UNDER 6 MONTHS OF AGE; CONSULT A PHYSICIAN BEFORE USE.
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENT: TITANIUM DIOXIDE 6.4%
INACTIVE INGREDIENT SECTION
OTHER INGREDIENTS: WATER (DEIONIZED), CAPRYLIC/CAPRIC TRIGLYCERIDE, GLYCERIN, JOJOBA ESTERS, PRUNUS AMYGDALUS DULCIS (SWEET ALMOND) OIL, HELIANTHUS ANNUUS (SUNFLOWER) SEED OIL, VP/EICOSENE COPOLYMER, SORBITAN PALMITATE, CYCLOPENTASILOXANE, CITRUS AURANTIUM DULCIS (ORANGE) PEEL WAX, OCTYLDODECYL, NEOPENTANOATE, POLYSORBATE 60, SORBITAN STEARATE, CETYL ALCOHOL, GLYCERYL STEARATE, PEG-100 STEARATE, DEMETHICONOL, RETINYL PALMITATE, TOCOPHERYL ACETATE, ORYZANOL, BISABOLOL, STEARYL GLYCYRRHETINATE, JASMINUM OFFICINALE, (JASMINE0 FLOWER EXTRACT, PERSEA GRATISSIMA (AVOCATO) OIL, TOCOPHEROL, ZINC OXIDE, SACCHARIDE HYDROLYSATE, MAGNESIUM ASPARTATE, BIOTIN, GLYCINE, ALANINE, UREA, ZEA MAYS (CORN) OIL, HYPERICUM PERFORATUM EXTRACT, XANTHAN GUM, ROYAL JELLY EXTRACT, CITRUS MEDICA LIMONUM (LEMON) FRUIT EXTRACT, HAMAMELIS VIRGINIANA (WITCH HAZEL) LEAF EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, ALOE BARBADENSIS LEAF JUICE, BEESWAX, CHRYSANTHEMUM INDICUM FLOWER EXTRACT, IMPERATA CYLINDRICA (LALANG GRASS) ROOT EXTRACT, PINUS PINASTER BARK/BUD EXTRACT, VITIS VINIFERA (GRAPE) SEED OIL, AESCULUS HIPPOCASTANUM (HORSE CHESTNUT) EXTRACT, PHENOXYETHANOL, METHYLPARABEN, PROPYLPARABEN, ETHYLPARABEN, BUTYLPARABEN, TRISODIUM EDTA, CITRIC ACID, FRAGRANCE.
WARNINGS SECTION
WARNING:FOR EXTERNAL USE ONLY. IF SWALLOWED, SEEK MEDICAL HELP OR CONTACT A POISON CONTROL CENTER IMMEDIATELY, IF CONTACT WITH EYES OCCURS, RINSE THOROUGHLY WITH WATER. DISCONTINUE USE AND CONSULT A PHYSICIAN IF PERSISTENT SIGNS OF IRRITATION OR RASH APPEAR.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
MM1
Jar 0.5 label
MM2
Jar 0.5 box
MM3
Jar 2.5 label
MM4
Jar 2.5 box
USES: HELPS PREVENT SUNBURNS
MM2
MM3
MM4
USES: HELPS PREVENT SUNBURNS
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62191-004-03 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d3c4-f6ea-e053-dbdaa90aa703 | OIL LIN® NATURAL EMULSION SUNSCREEN SPF 30 |
| 62191-004-04 | 2019-11-13 | C162847 | 48780-1 | 97449f38-d3c4-f6ea-e053-dbdaa90aa703 | OIL LIN® NATURAL EMULSION SUNSCREEN SPF 30 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62191-004-03 | Oi Lin Natural Sunscreen SPF 30 | 15 g in 1 JAR | EMULSION | 15 | 1 | |
| 62191-004-04 | Oi Lin Natural Sunscreen SPF 30 | 71 g in 1 JAR | EMULSION | 71 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ALANINE | INACTIVE INGREDIENT | OF5P57N2ZX | 1 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| Biotin | INACTIVE INGREDIENT | 6SO6U10H04 | 1 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| DENDRANTHEMA INDICUM FLOWER | INACTIVE INGREDIENT | I6OER6U04L | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| GAMMA ORYZANOL | INACTIVE INGREDIENT | SST9XCL51M | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| GREEN TEA LEAF | INACTIVE INGREDIENT | W2ZU1RY8B0 | 1 | |
| HAMAMELIS VIRGINIANA TOP | INACTIVE INGREDIENT | UDA30A2JJY | 1 | |
| HORSE CHESTNUT | INACTIVE INGREDIENT | 3C18L6RJAZ | 1 | |
| HYPERICUM PERFORATUM FLOWER | INACTIVE INGREDIENT | A6V4CUE7PV | 1 | |
| IMPERATA CYLINDRICA ROOT | INACTIVE INGREDIENT | VYT2JA85NH | 1 | |
| MAGNESIUM ASPARTATE | INACTIVE INGREDIENT | R17X820ROL | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| OCTYLDODECYL NEOPENTANOATE | INACTIVE INGREDIENT | X8725R883T | 1 | |
| ORANGE PEEL WAX | INACTIVE INGREDIENT | 0U715N387C | 1 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| SUNFLOWER OIL | INACTIVE INGREDIENT | 3W1JG795YI | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| YELLOW WAX | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Products#
Every source-derived product name is available through these pages.
- Oi Lin Natural Sunscreen SPF 30
- SUNSCREEN, TITANIUM DIOXIDE
- TITANIUM DIOXIDE
- ALANINE
- ALOE VERA LEAF
- YELLOW WAX
- Biotin
- BUTYLPARABEN
- Cetyl Alcohol
- CYCLOMETHICONE 5
- DENDRANTHEMA INDICUM FLOWER
- ETHYLPARABEN
- GAMMA ORYZANOL
- Glycerin
- GLYCERYL MONOSTEARATE
- GREEN TEA LEAF
- HAMAMELIS VIRGINIANA TOP
- HORSE CHESTNUT
- HYPERICUM PERFORATUM FLOWER
- IMPERATA CYLINDRICA ROOT
- MAGNESIUM ASPARTATE
- MEDIUM-CHAIN TRIGLYCERIDES
- METHYLPARABEN
- OCTYLDODECYL NEOPENTANOATE
- ORANGE PEEL WAX
- PEG-100 STEARATE
- SUNFLOWER OIL
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62191-004 | 62191-004-03, 62191-004-04 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUPPOSITORY / VAGINAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, CHEWABLE / ORAL | 1.28 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 82 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | 30 mg | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | TABLET, COATED / ORAL | 213.7 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / TOPICAL | 216 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / SUBLINGUAL | 1.23 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| YELLOW WAX | YELLOW WAX | 2ZA36H0S2V | CAPSULE / ORAL | 44 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | AEROSOL, FOAM / TOPICAL | 10.87 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE / ORAL | 7 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / NASAL | 250 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / VAGINAL | 100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 990.3 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | LOTION / TOPICAL | 4 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL / TOPICAL | 1.16 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SPRAY / TOPICAL | 0.2 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION, CONCENTRATE / ORAL | 1 mg/1ml | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CAPSULE / ORAL | 4771 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, EXTENDED RELEASE / ORAL | 0.37 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, COATED / ORAL | 0.25 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY / TOPICAL | 540 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 59 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | SOLUTION / RECTAL | 0.01 %w/v | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | LIQUID / TOPICAL | 0.02 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET / ORAL | 2 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED / ORAL | NA | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / VAGINAL | 0.75 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / VAGINAL | 22 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | GRANULE, FOR SOLUTION / ORAL | 14 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM / TOPICAL | 3000 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CREAM / TOPICAL | 3300 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 63e98caf-8864-4efd-8b07-bb7279981d63 | 8c0b5e30-27b4-481c-ac1d-0733adedcd66 | 2012-02-06 | Warnings | 63e98caf-8864-4efd-8b07-bb7279981d63 8c0b5e30-27b4-481c-ac1d-0733adedcd66 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.